BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38330165)

  • 21. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
    N'Diaye N; Tremblay J; Hamet P; De Herder WW; Lacroix A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2781-5. PubMed ID: 9709947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KDM1A inactivation causes hereditary food-dependent Cushing syndrome.
    Vaczlavik A; Bouys L; Violon F; Giannone G; Jouinot A; Armignacco R; Cavalcante IP; Berthon A; Letouzé E; Vaduva P; Barat M; Bonnet F; Perlemoine K; Ribes C; Sibony M; North MO; Espiard S; Emy P; Haissaguerre M; Tauveron I; Guignat L; Groussin L; Dousset B; Reincke M; Fragoso MC; Stratakis CA; Pasmant E; Libé R; Assié G; Ragazzon B; Bertherat J
    Genet Med; 2022 Feb; 24(2):374-383. PubMed ID: 34906447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
    Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
    Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
    Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
    Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
    Hage M; Viengchareun S; Brunet E; Villa C; Pineau D; Bouligand J; Teglas JP; Adam C; Parker F; Lombès M; Tachdjian G; Gaillard S; Chanson P; Tosca L; Kamenický P
    J Clin Endocrinol Metab; 2018 May; 103(5):1929-1939. PubMed ID: 29474559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically silent somatotroph adenomas are common.
    Wade AN; Baccon J; Grady MS; Judy KD; O'Rourke DM; Snyder PJ
    Eur J Endocrinol; 2011 Jul; 165(1):39-44. PubMed ID: 21493729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.
    Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB
    Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836
    [No Abstract]   [Full Text] [Related]  

  • 31. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.
    Lopes MB; Gaylinn BD; Thorner MO; Stoler MH
    Am J Pathol; 1997 Jun; 150(6):1885-91. PubMed ID: 9176381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone secretion by pituitary adenomas is characterized by increased disorderliness and spikiness but more regular pulsing.
    Roelfsema F; Pereira AM; Biermasz NR; Veldhuis JD
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3836-44. PubMed ID: 25014002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia.
    Bertherat J; Bourdeau I; Bouys L; Chasseloup F; Kamenický P; Lacroix A
    Endocr Rev; 2023 Jul; 44(4):567-628. PubMed ID: 36548967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose-dependent insulinotropic polypeptide induced growth hormone secretion in acromegaly.
    Umahara M; Okada S; Ohshima K; Mori M
    Endocr J; 2003 Oct; 50(5):643-50. PubMed ID: 14614222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
    Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
    Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly.
    Lekva T; Berg JP; Fougner SL; Olstad OK; Ueland T; Bollerslev J
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1506-14. PubMed ID: 22585092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.